Carboplatin Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Carboplatin Injection (injection) from Hospira, Inc., A Pfizer Company with status Current. The shortage was first posted on Apr 28, 2023. Reported reason: Other
Shortage details
- Status
- Current
- Company
- Hospira, Inc., A Pfizer Company
- Package NDC
- 61703-262-05
- Dosage Form
- Injection
- Presentation
- Carboplatin, Injection, 450 mg/45 mL (10 mg/mL) (NDC 61703-262-05)
- Initial Posting
- Apr 28, 2023
Reason
Other